Pre-randomization Atrioventricular Interval Modulation Therapy (“AVIM Therapy”) set-up data from the MODERATO II randomized, prospective, ...
4h
Mozart Therapeutics Announces Positive Interim Phase 1 Data in Adults with Stage 3 Type I Diabetes
Mozart Therapeutics, the leading developer of CD8 Treg network modulators for the treatment of autoimmune disease, today ...
Data showcase advances across oncology pipeline including pan-mutant BRAF, CBL-B and AURKA programsPresentations reinforce potential of degraders ...
MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, developed a technology based on quantum key distribution protocol and quantum random number ...
Marks First In-Human Clinical Study Demonstrating the Value of Immuno-Pharmacodynamics in the Assessment of Radioligand Therapy -- Novigenix AI Liquid Biopsy Platform Identifies Immune Activation ...
The Phase II trial enrolled 129 participants, of whom 94% had relapsing remitting multiple sclerosis, and 6% had secondary ...
Three posters accepted at AACR 2026 highlighting SK Life Science Labs' targeted protein degradation pipeline -- Programs featured: selective p300 and PRMT5 degraders -- p300 degrader data demonstrate: ...
AI data centers need to minimize energy, space, size, cooling and equipment resources. Solid-state, optical techniques for circuit switching are critical for this.
Light has always carried more than brightness. In this case, it also carries direction and twist. That mix may open a new ...
Traditional explanations of acupuncture often emphasize direct acupoint-organ relationships, focusing on local stimulation or ...
Marvell Technology’s acquisition of Polariton Technologies and its ties with POET Technologies ignited sharp gains in AI infrastructure stocks. The deal strengthens Marvell’s optical connectivity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results